Transforming Healthcare with Data
ASPISMED is a startup healthcare company located in Greece. We specialize in real world data software, providing innovative solutions for healthcare professionals and industries to improve patient care and outcomes. Our goal is to help bridge the gap between data and practice in the healthcare industry.
Discovery Mode
This feature is designed to discover, uncover, and generate new insights that went undetected during clinical trials. It represents an innovation powered by proprietary molecular-level pharmacodynamic data which, combined with patient-generated Real-World Evidence (RWE), can accelerate and enhance treatment safety while optimizing therapeutic efficacy.
Click here to learn more:
Clinical Mode
This mode operates as a framework grounded in international medical literature and established standards regarding medication intake and the patient's current clinical status. The algorithm generates real-time notifications on the patient's mobile device to monitor and verify their condition. In the event a side effect is detected, the patient is immediately prompted to consult their physician, while the healthcare provider is simultaneously updated.
Click here to learn more:
Securing Patients Data
In an era of tightening regulations for sensitive healthcare data, ASPISMED's software addresses the critical need for absolute privacy. For this reason, our architecture natively integrates all necessary safeguards to secure data throughout the entire transmission pipeline, while simultaneously maintaining maximum operational efficiency.
Click here to learn more:
For Pharma Industry
The adoption of ASPISMED's RWE-based strategies by the pharmaceutical industry offers unique advantages in terms of therapeutic indications, patient satisfaction, and treatment safety. Click on the download form for a complete guide
About the founder: For Investors
ASPISMED was founded by a visionary licensed Pharmacist and HealthTech entrepreneur who established his own independent pharmacy 20 years ago at the age of 28. Holding an advanced Master's degree (MSc) in Pharmaceutical Marketing, he bridges deep clinical insights with strategic market execution. The catalyst for ASPISMED stemmed from his direct corporate and frontline observations: witnessing severe, undocumented drug toxicities in real-world patients that legal manufacturing labels only integrated years later. Leveraging a sophisticated background in molecular mechanisms of action, he successfully predicted critical post-market adverse profiles—such as those that led to the global withdrawal of high-profile therapeutics like Acomplia.
Recognizing the systemic inertia within traditional pharmaceutical channels, and further validated by the global surge in accelerated vaccine and drug approvals during the COVID-19 era, he realized that proactive pharmacovigilance required an entirely new digital paradigm. With the advent of advanced Artificial Intelligence, he captured the dynamic tool necessary to scale his vision, engineering ASPISMED to transform real-world patient signal tracking into the global standard for modern, predictive therapeutics and data integrity.
ASPISMED's multidimensional approach establishes the ideal conditions for a collaborative investor ecosystem with mutual benefits and synergy for all. Through ASPISMED, pharmaceutical companies, insurance payors, patients, and clinicians discover, utilize, and capitalize on real-world therapeutic data. Click download Pesentation For Investors for more information
Contact us!
Welcome to ASPISMED, your trusted partner in real world data software for the healthcare industry. We specialize in providing cutting-edge solutions for data collection, analysis, and management, helping healthcare organizations streamline their processes and make informed decisions.